Food Allergy Diagnosis & Treatment Market to Surpass USD 11.2 Billion by 2034

Pune, India, November 11, 2025 - The global Food Allergy Diagnosis & Treatment Market is projected to grow from USD 6.1 billion in 2024 to USD 11.2 billion by 2034, registering a CAGR of 6.2 %, according to Exactitude Consultancy. The surge in food allergy prevalence, particularly among children, coupled with advances in molecular diagnostics, immunotherapy, and AI-driven allergy profiling, is fueling robust market expansion worldwide.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49146

Key Takeaways
• Market Size (2024): USD 6.1 billion
• Forecast (2034): USD 11.2 billion
• CAGR (2025-2034): 6.2 %
• Leading Companies: Thermo Fisher Scientific Inc., Danaher Corporation, ALK-Abelló A/S, Siemens Healthineers, Nestlé Health Science, Omega Diagnostics Group, DBV Technologies, Stallergenes Greer, bioMérieux SA, and Bio-Rad Laboratories Inc.
• Top Products & Services: In vitro diagnostic (IVD) kits, skin-prick tests (SPT), oral food challenges (OFC), and sublingual/oral immunotherapy (OIT, SLIT).

Market Story
Food allergies now affect over 250 million people globally, with peanut, tree-nut, milk, egg, and shellfish allergies among the most prevalent. Increasing diagnostic awareness and government-led health campaigns are pushing early detection and personalized treatment programs.

Cutting-edge technologies like component-resolved diagnostics (CRD) and microarray-based allergen identification are improving accuracy and reducing false-positive results. Meanwhile, research into peptide-based desensitization therapies and biologics such as omalizumab is reshaping long-term management for severe allergy patients.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49146/food-allergy-diagnosis-treatment-market

Market Segmentation
• By Diagnosis Type:
o Skin Prick Tests (SPT)
o Blood Tests (IgE and CRD Assays)
o Oral Food Challenges (OFC)
o Patch Tests

• By Treatment Type:
o Immunotherapy (OIT, SLIT)
o Antihistamines and Epinephrine Auto-Injectors
o Biologic Therapies
o Dietary Management & Education

• By End User:
o Hospitals & Clinics
o Diagnostic Centers & Laboratories
o Academic Research Institutes

• By Region:
o North America: Dominates with strong allergy-testing infrastructure and FDA-approved immunotherapies.
o Europe: Growth driven by public screening programs and rising nut-allergy incidence.
o Asia Pacific: Fastest growth with urban dietary changes and higher pediatric allergy rates.
o Latin America & MEA: Improving access to affordable diagnostics and allergy-care training.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49146

Recent Developments
• 2025: Thermo Fisher Scientific launched the ImmunoCAP Allergen X6 Panel, offering multiplexed CRD for food and inhalant allergens.
• 2024: Danaher's Beckman Coulter introduced a fully automated IgE testing platform for high-volume clinical labs.
• 2023: ALK-Abelló received EMA approval for its sublingual immunotherapy tablet for peanut allergy.
• 2022: DBV Technologies advanced its Viaskin patch immunotherapy for pediatric milk allergies to Phase III trials.

Expert Quote
"The next decade will see food allergy diagnosis become faster and more personalized. AI-driven testing and biologic therapies are reshaping treatment from reaction management to tolerance development," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Market Drivers
1. Rising Global Prevalence of Food Allergies: Accelerating screening and treatment demand.
2. Technological Advancements: Component-based and molecular diagnostic tools boost accuracy.
3. Emergence of Biologics and Immunotherapy: Shifting from symptom control to disease modification.
4. Government Support and Education Campaigns: Widening access to testing and anaphylaxis management.

Forecast Outlook
From 2025 to 2034, the market will see rapid integration of AI diagnostic assistants, wearable anaphylaxis monitors, and DNA-based personalized treatment models. Collaborations between biotech firms and academic allergy centers will accelerate the development of long-acting immunotherapies.

Conclusion
The Food Allergy Diagnosis & Treatment Market is on track for steady growth as technological innovation meets rising clinical demand. With new molecular tools, digital health integration, and advances in desensitization therapies, patients can expect faster diagnosis and long-term relief from severe food allergies.

This report is also available in the following languages : Japanese (食物アレルギーの診断と治療), Korean (식품 알레르기 진단 및 치료), Chinese (食物过敏诊断与治疗), French (Diagnostic et traitement des allergies alimentaires), German (Diagnose und Behandlung von Nahrungsmittelallergien), and Italian (Diagnosi e trattamento delle allergie alimentari), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49146

Our More Reports:

HIV Diagnosis Market
https://exactitudeconsultancy.com/reports/26921/hiv-diagnosis-market

Gene Panel Market
https://exactitudeconsultancy.com/reports/30235/gene-panel-market

Hepatitis Test Solution Diagnosis Market
https://exactitudeconsultancy.com/reports/49130/hepatitis-test-solution-diagnosis-market

Asperger Syndrome Market
https://exactitudeconsultancy.com/reports/51795/asperger-syndrome-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.